TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
ARAY

Accuray Incorporated

Healthcare · Medical Devices

0.2534$ -3.1% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Income Statement

Accuray Incorporated (ARAY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 101 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size % Per share
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ARAY
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
87 88 97 112 91 100 100 114 96 102 103 117 90 99 100 95 85 97 103 111 107 116 96 110 96 115 118 118 104 107 101 134 102 116 113 128 94 102 105 101 402
55 56 62 69 53 61 64 66 58 64 63 71 57 61 60 55 50 57 63 67 68 74 61 67 62 72 79 81 64 71 72 96 67 74 82 89 67 78 80 65 290
31 31 35 43 38 39 36 48 38 38 40 46 33 38 39 40 35 41 40 44 40 43 35 43 35 43 39 38 39 36 29 38 34 42 32 39 27 24 25 36 111
12 12 12 13 14 15 14 15 14 14 13 16 13 13 11 12 12 12 13 15 14 15 14 15 14 15 14 14 14 15 11 9.5 12 14 11 11 11 11 8.2 7.6 38
11 10 11 11 11 12 12 13 16 10 12 12 11 9.9 8.9 11 8.9 10 11 11 11 11 10 12 12 12 11 13 13 13 12 11 13 12 11 12 15 10 11 9.6 45
38 36 37 40 40 40 40 45 43 39 38 43 37 34 31 35 30 33 35 40 37 39 35 41 37 40 36 38 37 40 34 32 37 37 31 35 38 30 28 43 138
-6.5 -4.8 -1.3 2.8 -2.1 -1.0 -3.8 3.1 -4.7 -0.9 2.9 3.3 -4.3 3.6 8.0 5.2 5.5 8.2 4.4 4.1 2.4 4.0 -0.3 2.0 -2.2 2.7 2.3 -0.5 2.2 -4.0 -4.6 6.8 -2.1 4.7 1.0 4.2 -11 -5.5 -2.5 -7.1 -26
3.8 3.4 3.3 6.9 3.7 3.7 3.9 3.7 3.5 3.5 3.7 4.3 4.2 4.7 – – 4.4 – 4.3 3.8 2.0 2.1 2.0 2.1 2.3 2.6 2.7 3.0 2.9 2.9 2.9 2.9 3.0 2.9 15 4.2 8.1 7.7 8.4 11 35
-11 -8.9 -4.2 -4.9 -8.6 -4.8 -8.3 -1.4 -8.7 -4.2 -0.9 -0.5 -8.7 11 2.9 0.1 0.7 5.1 0.3 -11 -0.6 0.7 -0.6 -1.4 -5.1 -0.8 1.1 -2.0 -1.0 -8.7 -5.9 3.9 -3.3 3.2 -0.8 2.1 -21 -13 -11 -1.5 -47
-0.6 0.4 0.8 0.4 0.8 0.0 0.6 -0.4 0.5 0.5 0.2 0.9 0.6 0.7 0.3 0.3 0.3 0.3 0.7 0.4 0.4 0.5 0.4 2.0 0.3 1.0 0.5 0.6 1.9 0.9 0.4 0.5 0.6 0.7 0.5 0.9 0.5 0.6 0.5 0.4 1.9
-9.9 -9.4 -5.0 -5.3 -9.4 -4.7 -8.9 -0.9 -9.2 -4.6 -1.2 -1.4 -9.4 11 2.6 -0.2 0.4 4.8 -0.4 -11 -1.0 0.2 -1.0 -3.5 -5.4 -1.9 0.6 -2.6 -3.0 -9.6 -6.3 3.4 -4.0 2.5 -1.3 1.1 -22 -14 -12 -1.9 -49
-1.9 -0.2 3.3 5.6 0.5 1.5 -1.4 4.7 -2.6 1.2 4.8 7.7 -2.4 5.5 9.8 18 7.1 9.9 6.0 -4.3 2.9 4.2 2.7 1.3 -1.7 3.0 4.9 2.1 3.1 -4.3 -1.4 8.3 1.1 7.6 3.6 7.9 -11 -3.3 -0.8 9.2 -6.4

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?